JFS Wealth Advisors’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.23K | Hold |
1,590
| – | – | ﹤0.01% | 1368 |
|
|
2025
Q1 | $2.82K | Hold |
1,590
| – | – | ﹤0.01% | 1338 |
|
|
2024
Q4 | $3.66K | Hold |
1,590
| – | – | ﹤0.01% | 1243 |
|
|
2024
Q3 | $5.63K | Hold |
1,590
| – | – | ﹤0.01% | 1080 |
|
|
2024
Q2 | $4.41K | Hold |
1,590
| – | – | ﹤0.01% | 1120 |
|
|
2024
Q1 | $10.5K | Hold |
1,590
| – | – | ﹤0.01% | 799 |
|
|
2023
Q4 | $4.85K | Hold |
1,590
| – | – | ﹤0.01% | 1069 |
|
|
2023
Q3 | $2.42K | Hold |
1,590
| – | – | ﹤0.01% | 1288 |
|
|
2023
Q2 | $2.85K | Hold |
1,590
| – | – | ﹤0.01% | 1248 |
|
|
2023
Q1 | $1.97K | Hold |
1,590
| – | – | ﹤0.01% | 1372 |
|
|
2022
Q4 | $3.77K | Hold |
1,590
| – | – | ﹤0.01% | 1109 |
|
|
2022
Q3 | $7K | Hold |
1,590
| – | – | ﹤0.01% | 885 |
|
|
2022
Q2 | $8K | Hold |
1,590
| – | – | ﹤0.01% | 850 |
|
|
2022
Q1 | $16K | Hold |
1,590
| – | – | ﹤0.01% | 668 |
|
|
2021
Q4 | $18K | Hold |
1,590
| – | – | ﹤0.01% | 592 |
|
|
2021
Q3 | $32K | Buy |
+1,590
| New | +$32K | ﹤0.01% | 478 |
|